Results 301 to 310 of about 452,734 (338)
Some of the next articles are maybe not open access.
Nihon rinsho. Japanese journal of clinical medicine, 2015
Many patients with type 2 diabetes mellitus(T2DM) do not achieve satisfactory glycemic control by monotherapy alone, and often require multiple oral hypoglycemic agents (OHAs). Combining OHAs with complementary mechanisms of action is fundamental to the management of T2DM.
openaire +1 more source
Many patients with type 2 diabetes mellitus(T2DM) do not achieve satisfactory glycemic control by monotherapy alone, and often require multiple oral hypoglycemic agents (OHAs). Combining OHAs with complementary mechanisms of action is fundamental to the management of T2DM.
openaire +1 more source
Prescription of fixed dose combination drugs for diarrhoea
Indian Journal of Medical Ethics, 2007Fixed-dose combinations (FDCs) of an antiprotozoal and an antibacterial, for treatment of diarrhoea, have been available in the Indian pharmaceutical market for about a decade. There is little evidence to substantiate this combination therapy. We evaluated 2,163 physician prescriptions for diarrhoea and found that 59 per cent of prescriptions were for ...
openaire +2 more sources
Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis.
American Journal of Medicine, 2019The US Food and Drug Administration recently granted an approved indication for the first fixed-dose combination antihypertensive (amlodipine) and nonsteroidal anti-inflammatory drug (celecoxib) for treatment of comorbid hypertension and osteoarthritis ...
Steven M. Smith, R. Cooper‐DeHoff
semanticscholar +1 more source
Anti-obesity fixed-dose combinations
The British Journal of Diabetes & Vascular Disease, 2012The management of hypertension, dyslipidaemia and hyperglycaemia often requires multiple medications that combine two or more agents with different modes of action to give additive efficacy. In some situations lower doses of two agents with different modes of action can achieve greater efficacy than a high dose of one agent.
Clifford J Bailey, Caroline Day
openaire +1 more source
Umeclidinium/vilanterol fixed-dose combination for COPD
Drugs of Today, 2014Chronic obstructive pulmonary disease (COPD) mortality is projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly tobacco smoke exposure. Umeclidinium/vilanterol at 62.5/25 μg is the fixed-dose combination of a long-acting antimuscarinic agent and a long-acting β2-adrenoceptor agonist that ...
openaire +2 more sources
Determination of metformin in fixed-dose combination tablets by ATR-FTIR spectroscopy
Chemical Data Collections, 2022B. Sabbagh +4 more
semanticscholar +1 more source
Pharmaceutical application and development of fixed-dose combination: dosage form review
Journal of Pharmaceutical Investigation, 2021Dong-Wook Kim, Kwon-Yeon Weon
semanticscholar +1 more source
Combine and conquer: advantages and disadvantages of fixed‐dose combination therapy
Diabetes, Obesity and Metabolism, 2012The majority of patients with type 2 diabetes mellitus ( T2DM ) do not achieve the glycaemic goals recommended by leading diabetes organizations using monotherapy alone, and often require multiple antihyperglycaemic agents to achieve glycaemic control. Fixed‐dose combination (
openaire +2 more sources